Importance of gut microbiome regulation for the prevention and recovery process after SARS‑CoV‑2 respiratory viral infection (Review)
- Authors:
- Nuroh Najmi
- Imam Megantara
- Lovita Andriani
- Hanna Goenawan
- Ronny Lesmana
-
Affiliations: Department of Oral Biology, Faculty of Dentistry, Universitas Padjadjaran, Bandung, West Java 45363, Indonesia, Division of Biological Activty Central Laboratory, Universitas Padjadjaran, Bandung, West Java 45363, Indonesia, Faculty of Animal Husbandry, Universitas Padjadjaran, Bandung, West Java 45363, Indonesia - Published online on: February 14, 2022 https://doi.org/10.3892/br.2022.1508
- Article Number: 25
-
Copyright: © Najmi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Chan JFW, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, et al: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet. 395:514–523. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kang MK, Kim KO, Kim MC, Cho JH, Kim SB, Park JG, Kim KH, Lee SH, Jang BI and Kim TN: Clinical characteristics of coronavirus disease 2019 patients with diarrhea in Daegu. Korean J Intern Med. 35:1261–1269. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tariq R, Saha S, Furqan F, Hassett L, Pardi D and Khanna S: Prevalence and Mortality of COVID-19 patients with gastrointestinal symptoms: A systematic review and Meta-analysis. Mayo Clin Proc. 95:1632–1648. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Graham MS, Sudre CH, May A, Antonelli M, Murray B, Varsavsky T, Kläser K, Canas LS, Molteni E, Modat M, et al: Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: An ecological study. Lancet Public Heal. 6:e335–e345. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Cascella M, Rajnik M, Cuomo A, Dulebohn SC and Di Napoli R: Features, evaluation and treatment coronavirus (COVID-19. Review from StatPearls Publishing, Treasure Island (FL), 10 Mar, 2020. | |
|
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, Li P, Hu B, Wang J, Hu C, et al: Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 115:766–773. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Nogueira-de-Almeida CA, Del Ciampo LA, Ferraz IS, Del Ciampo IRL, Contini AA and Ued FDV: COVID-19 and obesity in childhood and adolescence: A clinical review. J Pediatr (Rio J). 95:546–558. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Yang J, Hu J and Zhu C: Obesity aggravates COVID-19: A systematic review and meta-analysis. J Med Virol. 93:257–261. 2021. | |
|
Gao F, Zheng KI, Wang XB, Sun QF, Pan KH, Wang TY, Chen YP, Targher G, Byrne CD, George J and Zheng MH: Obesity is a risk factor for greater COVID-19 severity. Diabetes Care. 43:e72–e74. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Al-Salameh A, Lanoix JP, Bennis Y, Andrejak C, Brochot E, Deschasse G, Dupont H, Goeb V, Jaureguy M, Lion S, et al: Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes. Diabetes Metab Res Rev. 37(e3388)2019.PubMed/NCBI View Article : Google Scholar | |
|
Wang F, Yang Y, Dong K, Yan Y, Zhang S, Ren H, Yu X and Shi X: Clinical characteristics of 28 patients with Diabetes and COVID-19 in Wuhan, China. Endocr Pract. 26:668–674. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Li J, Wang X, Chen J, Zuo X, Zhang H and Deng A: COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 22:1935–1941. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Khan M, Mathew BJ, Gupta P, Garg G, Khadanga S, Vyas AK and Singh AK: Gut dysbiosis and il-21 response in patients with severe covid-19. Microorganisms. 9(1292)2021.PubMed/NCBI View Article : Google Scholar | |
|
Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, et al: Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 159:944–955.e8. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kim HN, Joo EJ, Lee CW, Ahn KS, Kim HL, Park Dong-II and Park SK: Reversion of gut microbiota during the recovery Phase in patients with asymptomatic or mild Covid-19: Longitudinal study. Microorganisms. 9(1237)2021.PubMed/NCBI View Article : Google Scholar | |
|
Moreira-Rosário A, Marques C, Pinheiro H, Araújo JR, Ribeiro P, Rocha R, Mota I, Pestana D, Ribeiro R, Pereira A, et al: Gut microbiota diversity and C-reactive protein are predictors of disease severity in COVID-19 patients. Front Microbiol. 12(705020)2021.PubMed/NCBI View Article : Google Scholar | |
|
Ren Z, Wang H, Cui G, Lu H, Wang L, Luo H, Chen X, Ren H, Sun R, Liu W, et al: Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 70:1253–1265. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Groves HT, Higham SL, Moffatt MF, Cox MJ and Tregoning JS: Respiratory viral infection alters the gut microbiota by inducing Inappetence. MBio. 11:e03236–19. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Aljabr W, Alruwaili M, Penrice-Randal R, Alrezaihi A, Harrison AJ, Ryan Y, Bentley E, Jones B, Alhatlani BY, AlShahrani D, et al: Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS. mSphere. 6(e0021921)2021.PubMed/NCBI View Article : Google Scholar | |
|
Raman R, Patel KJ and Ranjan K: COVID-19: Unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies. Biomolecules. 11(993)2021.PubMed/NCBI View Article : Google Scholar | |
|
Trypsteen W, Van Cleemput J, Snippenberg WV, Gerlo S and Vandekerckhove L: On the whereabouts of SARS-CoV-2 in the human body: A systematic review. PLoS Pathog. 16(e1009037)2020.PubMed/NCBI View Article : Google Scholar | |
|
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, et al: First Case of 2019 novel coronavirus in the united states. N Engl J Med. 382:929–936. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, et al: Clinical characteristics of coronavirus disease 2019 in china. N Engl J Med. 382:1708–1720. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, Falck-Ytter Y and El-Serag HB: AGA Institute. Electronic address: simpleewilson@gastro.org. AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, Meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 159:320–334.e27. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang J, Garrett S and Sun J: Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19. Genes Dis. 8:385–400. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Xiao F, Tang M, Zheng X, Liu Y, Li X and Shan H: Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 158:1831–1833.e3. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Clemente-Suárez VJ, Ramos-Campo DJ, Mielgo-Ayuso J, Dalamitros AA, Nikolaidis PA, Hormeño-Holgado A and Tornero-Aguilera JF: Nutrition in the actual covid-19 pandemic. A narrative review. Nutrients. 13(1924)2021.PubMed/NCBI View Article : Google Scholar | |
|
Liang X, Zhou R, Li Y, Yang L, Su M and Lai KP: Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease. Aging (Albany NY). 13:15785–15800. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Rajpal A, Rahimi L and Ismail-Beigi F: Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes. 12:895–908. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Penninger JM, Grant MB and Sung JJY: The role of angiotensin converting enzyme 2 in modulating gut microbiota, intestinal inflammation, and coronavirus infection. Gastroenterology. 160:39–46. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, Sigl V, Hanada T, Hanada R, Lipinski S, et al: ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 487:477–481. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Yang T, Chakraborty S, Saha P, Mell B, Cheng X, Yeo JY, Mei X, Zhou G, Mandal J, Golonka R, et al: Gnotobiotic rats reveal that gut microbiota regulates colonic mRNA of Ace2, the receptor for SARS-CoV-2 Infectivity. Hypertension. 76:e1–e3. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Sánchez B, Delgado S, Blanco-Míguez A, Lourenço A, Gueimonde M and Margolles A: Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res. 61(1600240)2017.PubMed/NCBI View Article : Google Scholar | |
|
Putignani L, Del Chierico F, Petrucca A, Vernocchi P and Dallapiccola B: The human gut microbiota: A dynamic interplay with the host from birth to senescence settled during childhood. Pediatr Res. 76:2–10. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Hills RD Jr, Pontefract BA, Mishcon HR, Black CA, Sutton SC and Theberge CR: Gut Microbiome: Profound implications for diet and disease. Nutrients. 11(1613)2019.PubMed/NCBI View Article : Google Scholar | |
|
Villapol S: Gastrointestinal symptoms associated with COVID-19: Impact on the gut microbiome. Transl Res. 226:57–69. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lv Y, Qin X, Jia H, Chen S, Sun W and Wang X: The association between gut microbiota composition and BMI in Chinese male college students, as analysed by next-generation sequencing. Br J Nutr. 122:986–995. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Wiertsema SP, van Bergenhenegouwen J, Garssen J and Knippels LMJ: The interplay between the gut microbiome and the immune system in the context of infectious diseases throughout life and the role of nutrition in optimizing treatment strategies. Nutrients. 13(886)2021.PubMed/NCBI View Article : Google Scholar | |
|
Mullish BH, Marchesi JR, McDonald JAK, Pass DA, Masetti G, Michael DR, Plummer S, Jack AA, Davies TS, Hughes TR and Wang D: Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: Should we be considering probiotics during viral pandemics? Gut Microbes. 13:1–9. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Aktas B and Aslim B: Gut-lung axis and dysbiosis in COVID-19. Turk J Biol. 44:265–272. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Dang AT and Marsland BJ: Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. 12:843–850. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Taco-Masias AA, Fernandez-Aristi AR, Cornejo-Tapia A, Aguilar-Luis MA, del Valle LJ, Silva-Caso W, Zavaleta-Gavidia V, Weilg P, Cornejo-Pacherres H, Bazán-Mayra J, et al: Gut microbiota in hospitalized children with acute infective gastroenteritis caused by virus or bacteria in a regional Peruvian hospital. PeerJ. 8(e9964)2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu B, Li M, Zhou Z, Guan X and Xiang Y: Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J Autoimmun. 111(102452)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang X, Shi L, Sun T and Guo K: Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients. BMC Microbiol. 21(78)2021.PubMed/NCBI View Article : Google Scholar | |
|
Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, Møller R, Jordan TX, Oishi K, Panis M, Sachs D, et al: Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 181:1036–1045.e9. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP, Chuang EY, Tai YC, Cheng C, Lin HY and Wu MS: Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease. J Neuroinflammation. 16(129)2019.PubMed/NCBI View Article : Google Scholar | |
|
He Y, Wang J, Li F and Shi Y: Main clinical features of COVID-19 and potential prognostic and therapeutic value of the microbiota in SARS-CoV-2 infections. Front Microbiol. 11(1302)2020.PubMed/NCBI View Article : Google Scholar | |
|
Brancaccio M, Mennitti C, Gentile A, Correale L, Buzzachera CF, Ferraris C, Montomoli C, Frisso G, Borrelli P and Scudiero O: Effects of the covid-19 pandemic on job activity, dietary Behaviours and physical activity habits of university population of Naples, federico II-Italy. Int J Environ Res Public Health. 18(1502)2021.PubMed/NCBI View Article : Google Scholar | |
|
Quiroga R, Nistal E, Estébanez B, Porras D, Juárez-Fernández M, Martínez-Flórez S, García-Mediavilla MV, de Paz JA, González-Gallego J, Sánchez-Campos S and Cuevas MJ: Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children. Exp Mol Med. 52:1048–1061. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Campbell SC, Wisniewski PJ, Noji M, McGuinness LR, Häggblom MM, Lightfoot SA, Joseph LB and Kerkhof LJ: The effect of diet and exercise on intestinal integrity and microbial diversity in mice. PLoS One. 11(e0150502)2016.PubMed/NCBI View Article : Google Scholar | |
|
Clarke SF, Murphy EF, O'Sullivan O, Lucey AJ, Humphreys M, Hogan A, Hayes P, O'Reilly M, Jeffery IB, Wood-Martin R, et al: Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 63:1913–1920. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Metsios GS, Moe RH and Kitas GD: Exercise and inflammation. Best Pract Res Clin Rheumatol. 34(101504)2020.PubMed/NCBI View Article : Google Scholar | |
|
da Silveira MP, da Silva Fagundes KK, Bizuti MR, Starck É, Rossi RC and de Resende E Silva DT: Physical exercise as a tool to help the immune system against COVID-19: An integrative review of the current literature. Clin Exp Med. 21:15–28. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Singh K and Rao A: Probiotics: A potential immunomodulator in COVID-19 infection management. Nutr Res. 87:1–12. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Lehtoranta L, Pitkäranta A and Korpela R: Probiotics in respiratory virus infections. Eur J Clin Microbiol Infect Dis. 33:1289–1302. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Celiberto LS, Pinto RA, Rossi EA, Vallance BA and Cavallini DCU: Isolation and characterization of potentially probiotic bacterial strains from mice: Proof of concept for personalized probiotics. Nutrients. 10(1684)2018.PubMed/NCBI View Article : Google Scholar | |
|
Tenorio-Jiménez C, Martínez-Ramírez MJ, Del Castillo-Codes I, Arraiza-Irigoyen C, Tercero-Lozano M, Camacho J, Chueca N, García F, Olza J, Plaza-Díaz J, et al: Lactobacillus reuteri V3401 reduces inflammatory biomarkers and modifies the gastrointestinal microbiome in adults with metabolic syndrome: The PROSIR study. Nutrients. 11(1761)2019.PubMed/NCBI View Article : Google Scholar | |
|
Walton GE, Gibson GR and Hunter KA: Mechanisms linking the human gut microbiome to prophylactic and treatment strategies for COVID-19. Br J Nutr. 126:219–227. 2021.PubMed/NCBI View Article : Google Scholar | |
|
McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, et al: The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med. 3(106ra106)2011.PubMed/NCBI View Article : Google Scholar | |
|
Redondo-Useros N, Gheorghe A, Díaz-Prieto LE, Villavisencio B, Marcos A and Nova E: Associations of probiotic fermented milk (PFM) and yogurt consumption with Bifidobacterium and Lactobacillus components of the gut microbiota in healthy adults. Nutrients. 11(651)2019.PubMed/NCBI View Article : Google Scholar | |
|
Holscher HD: Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 8:172–184. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Sanders ME, Merenstein DJ, Reid G, Gibson GR and Rastall RA: Probiotics and prebiotics in intestinal health and disease: From biology to the clinic. Nat Rev Gastroenterol Hepatol. 16:605–616. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Frei R, Akdis M and O'Mahony L: Prebiotics, probiotics, synbiotics, and the immune system: Experimental data and clinical evidence. Curr Opin Gastroenterol. 31:153–158. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Costabile A, Deaville ER, Morales AM and Gibson GR: Prebiotic potential of a maize-based soluble fibre and impact of dose on the human gut microbiota. PLoS One. 11(e0144457)2016.PubMed/NCBI View Article : Google Scholar | |
|
Antunes AEC, Vinderola G, Xavier-Santos D and Sivieri K: Food research international. Food Res Int. 37:195–197. 2004. | |
|
Oristrell J, Oliva JC, Casado E, Subirana I, Domínguez D, Toloba A, Balado A and Grau M: Vitamin D supplementation and COVID-19 risk: A population-based, cohort study. J Endocrinol Invest: Jul 17, 2021 (Epub ahead of print). | |
|
Robles-Vera I, Callejo M, Ramos R, Duarte J and Perez-Vizcaino F: Impact of Vitamin D deficit on the rat gut microbiome. Nutrients. 11(2564)2019.PubMed/NCBI View Article : Google Scholar | |
|
Thomas RL, Jiang L, Adams JS, Xu ZZ, Shen J, Janssen S, Ackermann G, Vanderschueren D, Pauwels S, Knight R, et al: Vitamin D metabolites and the gut microbiome in older men. Nat Commun. 11(5997)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wenban C, Heer RS, Baktash V, Kandiah P, Katsanouli T, Pandey A, Goindoo R, Ajaz A, Van den Abbeele K, Mandal AKJ and Missouris CG: Dexamethasone treatment may mitigate adverse effects of vitamin D deficiency in hospitalized Covid-19 patients. J Med Virol. 93:6605–6610. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Li R, Wu K, Li Y, Liang X, Tse WKF, Yang L and Lai KP: Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19. Aging (Albany NY). 12:15784–15796. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Huda MN, Ahmad SM, Kalanetra KM, Taft DH, Alam MJ, Khanam A, Raqib R, Underwood MA, Mills DA and Stephensen CB: Neonatal Vitamin A supplementation and Vitamin A status are associated with gut microbiome composition in Bangladeshi infants in early infancy and at 2 years of age. J Nutr. 149:1075–1088. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Murni IK, Prawirohartono EP and Triasih R: Potential role of vitamins and Zinc on acute respiratory infections including Covid-19. Glob Pediatr Heal. 8:1–8. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Iyer M, Jayaramayya K, Subramaniam MD, Lee SB, Dayem AA, Cho SG and Vellingiri B: COVID-19 : An update on diagnostic and therapeutic approaches. BMB Rep. 53:191–205. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Brusselaers N: Prescribed drugs and the microbiome. Gastroenterol Clin North Am. 48:331–342. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Zeppa SD, Agostini D, Piccoli G and Stocchi V: Gut microbiota status in COVID-19 : An unrecognized player? Front Cell Infect Microbiol. 10(576551)2020.PubMed/NCBI View Article : Google Scholar | |
|
Xu R, Lu R, Zhang T, Wu Q, Cai W, Han X, Wan Z, Jin X, Zhang Z and Zhang C: Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults. Commun Biol. 4(24)2021.PubMed/NCBI View Article : Google Scholar | |
|
Weersma RK, Zhernakova A and Fu J: Interaction between drugs and the gut microbiome. Gut. 69:1510–1519. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Dormont F, Brusini R, Cailleau C, Reynaud F, Peramo A, Gendron A, Mougin J, Gaudin F, Varna M and Couvreur P: Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents. Sci Adv. 6(eaaz5466)2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu L, Zheng Y, Yang J, Lv J and Fan C: Clinical observation on 13 novel coronavirus pneumonia cases treated with integrated traditional Chinese and Western Medicine. Zhejiang J Integr Tradit West Med. 30:349–351. 2020. | |
|
Dai T, Wang M, Wang P, Dai L, Dai R and Meng Q: Inhibition effects of eight anti-coronavirus drugs on glycosides metabolism and glycosidases in human gut microflora. Pharmazie. 76:195–201. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Pan ZY, Chang YX, Han N, Hou FY, Lee BJY, Zhi FC, Yang RF and Bi YJ: Short-term high-dose gavage of hydroxychloroquine changes gut microbiota but not the intestinal integrity and immunological responses in mice. Life Sci. 264(118450)2020.PubMed/NCBI View Article : Google Scholar | |
|
Million M, Lagier J, Gautret P, Colson P, Fournier PE, Amrane S, Hocquart M, Mailhe M, Esteves-Vieira V, Doudier B, et al: Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille France. Travel Med Infect Dis. 35(101738)2020.PubMed/NCBI View Article : Google Scholar | |
|
Parker EPK, Praharaj I, John J, Kaliappan SP, Kampmann B, Kang G and Grassly NC: Changes in the intestinal microbiota following the administration of azithromycin in a randomised placebo-controlled trial among infants in south India. Sci Rep. 7(9168)2017.PubMed/NCBI View Article : Google Scholar | |
|
Li R, Wang H, Shi Q, Wang N, Zhang Z, Xiong C, Liu J, Chen Y, Jiang L and Jiang Q: Effects of oral florfenicol and azithromycin on gut microbiota and adipogenesis in mice. PLoS One. 12(e0181690)2017.PubMed/NCBI View Article : Google Scholar | |
|
Ried K, Travica N, Dorairaj R and Sali A: Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. Nutr Res. 76:37–51. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Li Y, Liu X, Guo L, Li J, Zhong D, Zhang Y, Clarke M and Jin R: Traditional Chinese medicine for treating novel coronavirus (2019-nCoV) pneumonia: Protocol for a systematic review and meta-analysis. Syst Rev. 9(75)2020.PubMed/NCBI View Article : Google Scholar | |
|
de Munter J, Pavlov D, Gorlova A, Sicker M, Proshin A, Kalueff AV, Svistunov A, Kiselev D, Nedorubov A, Morozov S, et al: Increased oxidative stress in the prefrontal cortex as a shared feature of depressive- and PTSD-like syndromes: Effects of a standardized herbal antioxidant. Front Nutr. 8(661455)2021.PubMed/NCBI View Article : Google Scholar | |
|
Lyu M, Wang YF, Fan GW, Wang XY, Xu SY and Zhu Y: Balancing herbal medicine and functional food for prevention and treatment of cardiometabolic diseases through modulating gut microbiota. Front Microbiol. 8(2146)2017.PubMed/NCBI View Article : Google Scholar | |
|
Peterson CT, Sharma V, Uchitel S, Denniston K, Chopra D, Mills PJ and Peterson SN: Prebiotic potential of herbal medicines used in digestive health and disease. J Altern Complement Med. 24:656–665. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ma J, Zhou Q and Li H: Gut microbiota and nonalcoholic fatty liver disease: Insights on mechanisms and therapy. Nutrients. 9(1124)2017.PubMed/NCBI View Article : Google Scholar | |
|
Chen Z, Lv Y, Xu H and Deng L: Herbal medicine, gut microbiota, and COVID-19. Front Pharmacol. 12(646560)2021.PubMed/NCBI View Article : Google Scholar |
